4:10 Bonus & 1:10 Split; Record Date On Dec-10; Pharma Stock That Rose By 475% In 5-Yrs, In Focus Next Week

Achyut Healthcare Ltd, a penny stock engaged into pharmaceuticals sector, will be in focus during next week's trading session. The stock which is currently below Rs 80, is a multibagger with gains of at least 475% in 5 years. This multibagger has announced double rewards namely bonus issue and stock splits. To be eligible for the two corporate actions in Achyut, investors would require to hold the stock by the end of its record date.

Achyut Healthcare Share Price:

On BSE, Achyut's share price stood at Rs 78.04 apiece, with a market cap of Rs 131.31 crore. The stock's 52-week high and low is at Rs 86.39 apiece and Rs 40.23 apiece respectively.

Achyut share price has seen healthy growth in 2024 so far. On a month-on-month basis, the stock has zoomed by 17% on BSE, while in six months, the upside was about 44.44%. YTD, the stock has surged by a whopping 34.48%. In a year, the upside is about 59.18%. But in the long term, the stock has skyrocketed by 474.80% on BSE.

Achyut Healthcare Bonus Issue:

The company will reward investors with a 4:1 bonus issue. This means that the company will issue four new bonus Equity Shares of Re.1/- each for every Ten existing fully paid-up Equity Shares of Re.1/- each, held post-sub-division.

The record date for determining eligible shareholders for the bonus issue is fixed on Tuesday, December 10, 2024.

Achyut Healthcare Stock Split:

Before the bonus, Achyut will turn ex-date next week for its stock split ratio of 1:10. This means 1 Achyut stock with a face value of Rs 10 each will be sub-divided into ten smaller shares with a face value of Re 1 each.

Bonus shares are like incentives which are free of cost given to investors. Under this corporate action, new shares are issued at the existing Face Value of equity shares of the company. Hence, the face value remains the same post-bonus issue.

The record date is also December 10.

Generally, share splits mean that listed companies can split their existing shares into a ratio decided by them for a host of reasons. These could be done to improve liquidity, lessen the value of the stock, make it cheaper or simply attract new buying from both existing and new investors.

About Achyut Healthcare:

Achyut Healthcare Limited was incorporated as 'Achyut Securities Private Limited' on January 11, 1996, as a Private Limited Company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. The Company name was changed to 'Achyut Healthcare Private Limited', and a fresh Certificate of Incorporation dated November 26, 2002. Subsequently, the Company was converted from a Private Limited to a Public Limited and the name of the Company changed to 'Achyut Healthcare Limited', and a fresh Certificate of Incorporation dated November 30, 2021, was issued to the Company by the Registrar of Companies, Gujarat at Ahmedabad. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everolimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sodium IP/USP, DIBasic Calcium Phosphate IP, DIEthyl Phthalate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.